Yellowed Sclerae (Jaundice of the Eye Whites)

What is Yellowed sclerae?

Yellowed sclerae refer to a noticeable yellow discoloration of the white part of the eye (the sclera). The sclera normally appears bright white because it is made of dense connective tissue with a transparent covering (the conjunctiva). When bilirubin—a yellow pigment produced from the breakdown of red blood cells—accumulates in the bloodstream, it can deposit in the sclera, turning it yellow. This visual sign is often the first clue that a person is developing jaundice, a symptom rather than a disease itself.

Jaundice can result from a wide range of liver, gallbladder, blood, or metabolic problems. Because the eyes are highly vascular, the sclera is one of the most sensitive places to detect a rise in bilirubin, often before the skin becomes visibly yellow.

Common Causes

Below are the most frequent medical conditions that can lead to yellowed sclerae. The list includes both acute and chronic disorders.

• Hepatitis (A, B, C, D, E) – Inflammation of the liver impairs bilirubin processing.
• Alcoholic liver disease & cirrhosis – Long‑term alcohol abuse damages liver cells and bile flow.
• Gallstones & biliary obstruction – Blocked ducts prevent bilirubin excretion.
• Non‑alcoholic fatty liver disease (NAFLD) & steatohepatitis – Metabolic buildup of fat in the liver.
• Hemolytic anemia – Accelerated breakdown of red blood cells releases excess bilirubin.
• Genetic disorders (e.g., Gilbert’s syndrome, Crigler‑Najjar syndrome) – Enzyme deficiencies affecting bilirubin conjugation.
• Pancreatic cancer (especially head of pancreas) – Can compress the common bile duct.
• Drug‑induced liver injury – Acetaminophen overdose, certain antibiotics, statins, and herbal supplements.
• Viral infections (e.g., Epstein‑Barr, cytomegalovirus) – Can cause transient hepatitis.
• Sepsis or severe infection – May cause cholestasis (reduced bile flow) and jaundice.

Associated Symptoms

Yellowed sclerae seldom appear in isolation. The following signs commonly accompany ocular jaundice, depending on the underlying cause:

• Yellowing of the skin, especially the face and palms.
• Dark urine (tea‑colored) and pale, clay‑colored stools.
• Pruritus (itchy skin), especially on the arms and trunk.
• Abdominal discomfort or fullness, particularly in the right upper quadrant.
• Fatigue, weakness, or loss of appetite.
• Unexplained weight loss.
• Fever, chills, or night sweats (suggesting infection or malignancy).
• Joint or muscle pain (possible hemolysis).
• Bruising or easy bleeding (if liver synthetic function is impaired).

When to See a Doctor

Although mild, transient yellowing can sometimes be harmless (e.g., Gilbert’s syndrome), prompt medical evaluation is essential when any of the following occur:

• Yellowing persists for more than a few days or worsens.
• Accompanied by severe abdominal pain, especially if it radiates to the back.
• Dark urine, pale stools, or persistent itching.
• Fever > 100.4 °F (38 °C) or chills.
• Confusion, drowsiness, or difficulty concentrating (signs of hepatic encephalopathy).
• Unexplained bruising, bleeding, or severe fatigue.
• History of liver disease, heavy alcohol use, or recent medication changes.

These symptoms may indicate a serious underlying condition that requires prompt diagnosis and treatment.

Diagnosis

Healthcare professionals use a combination of history‑taking, physical examination, and targeted tests to pinpoint the cause of yellowed sclerae.

Clinical Evaluation

• History – Review medication use, alcohol intake, family liver disease, recent infections, and travel.
• Physical exam – Assess scleral color, abdominal tenderness, liver size, and signs of chronic liver disease (spider angiomas, palmar erythema).

Laboratory Tests

• Liver function panel – AST, ALT, alkaline phosphatase, GGT, bilirubin (total & direct).
• Complete blood count (CBC) – Detect hemolysis or infection.
• Coagulation profile (PT/INR) – Evaluates liver synthetic capacity.
• Serologic tests – Hepatitis A‑E panels, autoimmune markers (ANA, ASMA), and viral loads when indicated.
• Hemolysis work‑up – Haptoglobin, lactate dehydrogenase (LDH), reticulocyte count.

Imaging Studies

• Abdominal ultrasound – First‑line to look for gallstones, ductal dilation, or liver morphology.
• CT or MRI – Detailed assessment of tumors, pancreatic lesions, or complex biliary obstruction.
• MRCP (magnetic resonance cholangiopancreatography) – Non‑invasive view of bile ducts.

Special Procedures

• Liver biopsy – Reserved for unclear cases where chronic liver disease or infiltrative disorders are suspected.
• Endoscopic retrograde cholangiopancreatography (ERCP) – Diagnostic and therapeutic for biliary blockage.

Treatment Options

Treatment is directed at the underlying cause; the yellowing itself generally resolves once bilirubin levels normalize.

General Measures

• Stay hydrated – adequate fluid intake supports kidney clearance of bilirubin.
• Avoid alcohol and hepatotoxic substances.
• Maintain a balanced diet rich in fruits, vegetables, lean protein, and healthy fats.

Specific Medical Therapies

• Viral hepatitis – Antiviral agents (e.g., sofosbuvir/velpatasvir for HCV, entecavir or tenofovir for HBV).
• Alcoholic liver disease – Abstinence, nutritional support (thiamine, folate), and in severe cases, corticosteroids or liver transplantation evaluation.
• Biliary obstruction – Endoscopic stone extraction, stent placement, or surgical bypass.
• Hemolytic anemia – Treat the trigger (e.g., stop offending drug), use steroids for autoimmune hemolysis, or exchange transfusion in severe cases.
• Genetic syndromes – Often benign (Gilbert’s) and need no treatment; severe enzyme deficiencies (Crigler‑Najjar) may require phototherapy or liver transplant.
• Cancer – Oncology-directed treatment (resection, chemotherapy, radiation) combined with biliary drainage if obstructive jaundice is present.
• Drug‑induced liver injury – Immediate cessation of the offending drug and observation; N‑acetylcysteine for acetaminophen toxicity.

Symptomatic Relief

• Antihistamines or cholestyramine for pruritus.
• Ursodeoxycholic acid to improve bile flow in selected cholestatic conditions.
• Pain control with acetaminophen (avoid excess) or short‑acting opioids under supervision.

Prevention Tips

While not all causes are preventable, many risk factors can be modified:

• Limit alcohol consumption to ≤ 1 drink per day for women and ≤ 2 for men.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C transmission.
• Maintain a healthy weight; regular exercise lowers the risk of NAFLD.
• Use medications as prescribed; avoid unnecessary over‑the‑counter supplements.
• Seek prompt medical care for infections, especially fevers with abdominal pain.
• Adopt a diet low in saturated fat and high in fiber to support liver health.
• Screen high‑risk individuals (e.g., chronic alcohol users, HBV carriers) with regular liver function tests.

Emergency Warning Signs

Key Take‑aways

Yellowed sclerae are a visible marker of elevated bilirubin and often signal liver, biliary, or blood‑disorder problems. Early recognition, thorough evaluation, and treatment of the underlying cause improve outcomes and can prevent progression to serious liver disease. Whenever yellowing of the eyes appears with other systemic signs—or if you experience any emergency warning signs—seek medical care promptly.

References:

• Mayo Clinic. “Jaundice.” Mayoclinic.org. Accessed May 2026.
• American Liver Foundation. “Understanding Jaundice.” liverfoundation.org.
• Cleveland Clinic. “Causes of Yellowing of the Eyes.” clevelandclinic.org.
• National Institutes of Health (NIH). “Liver Disease: Diagnosis and Management.” NCBI Bookshelf.
• World Health Organization. “Hepatitis Fact Sheet.” who.int.